| Consensus on diagnosis and management of Cushing's disease: a guideline update M Fleseriu, R Auchus, I Bancos, A Ben-Shlomo, J Bertherat, NR Biermasz, ... The lancet Diabetes & endocrinology 9 (12), 847-875, 2021 | 589 | 2021 |
| Mutations in the deubiquitinase gene USP8 cause Cushing's disease M Reincke, S Sbiera, A Hayakawa, M Theodoropoulou, A Osswald, ... Nature genetics 47 (1), 31-38, 2015 | 578 | 2015 |
| Somatostatin receptors: from signaling to clinical practice M Theodoropoulou, GK Stalla Frontiers in neuroendocrinology 34 (3), 228-252, 2013 | 456 | 2013 |
| Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression M Theodoropoulou, J Zhang, S Laupheimer, M Paez-Pereda, C Erneux, ... Cancer research 66 (3), 1576-1582, 2006 | 274 | 2006 |
| The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease LG Perez-Rivas, M Theodoropoulou, F Ferraù, C Nusser, K Kawaguchi, ... The Journal of Clinical Endocrinology & Metabolism 100 (7), E997-E1004, 2015 | 217 | 2015 |
| Retinoic acid prevents experimental Cushing syndrome M Páez-Pereda, D Kovalovsky, U Hopfner, M Theodoropoulou, U Pagotto, ... The Journal of Clinical Investigation 108 (8), 1123-1131, 2001 | 214 | 2001 |
| Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis C Bellodi, O Krasnykh, N Haynes, M Theodoropoulou, G Peng, ... Cancer research 70 (14), 6026-6035, 2010 | 193 | 2010 |
| High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, ... European Journal of Endocrinology 165 (4), 509-515, 2011 | 185 | 2011 |
| Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids … U Pagotto, G Marsicano, F Fezza, M Theodoropoulou, Y Grubler, J Stalla, ... The Journal of Clinical Endocrinology & Metabolism 86 (6), 2687-2696, 2001 | 179 | 2001 |
| Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications ML Jaffrain-Rea, M Angelini, D Gargano, MA Tichomirowa, AF Daly, ... Endocrine-related cancer 16 (3), 1029-1043, 2009 | 170 | 2009 |
| The Expression of the Antiproliferative Gene ZAC Is Lost or Highly Reduced in Nonfunctioning Pituitary Adenomas U Pagotto, T Arzberger, M Theodoropoulou, Y Grübler, C Pantaloni, ... Cancer Research 60 (24), 6794-6799, 2000 | 154 | 2000 |
| Retinoic acid as a novel medical therapy for Cushing’s disease in dogs V Castillo, D Giacomini, M Páez-Pereda, J Stalla, M Labeur, ... Endocrinology 147 (9), 4438-4444, 2006 | 145 | 2006 |
| Efficacy of a dopamine–somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi … T Florio, F Barbieri, R Spaziante, G Zona, LJ Hofland, PM van Koetsveld, ... Endocrine-Related Cancer 15 (2), 583-596, 2008 | 134 | 2008 |
| Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function G Balsevich, AS Häusl, CW Meyer, S Karamihalev, X Feng, ML Pöhlmann, ... Nature communications 8 (1), 1725, 2017 | 132 | 2017 |
| Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells M Theodoropoulou, T Arzberger, Y Gruebler, ML Jaffrain-Rea, J Schlegel, ... Journal of Endocrinology 183 (2), 385-394, 2004 | 128 | 2004 |
| The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells V Cerovac, J Monteserin-Garcia, H Rubinfeld, M Buchfelder, M Losa, ... Cancer research 70 (2), 666-674, 2010 | 112 | 2010 |
| Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action D Giacomini, M Páez-Pereda, M Theodoropoulou, M Labeur, D Refojo, ... Endocrinology 147 (1), 247-256, 2006 | 110 | 2006 |
| A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal C Villa, A Vasiljevic, ML Jaffrain-Rea, O Ansorge, S Asioli, V Barresi, ... Virchows Archiv 475, 687-692, 2019 | 102 | 2019 |
| Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds MA Tichomirowa, M Lee, A Barlier, AF Daly, I Marinoni, ML Jaffrain-Rea, ... Endocrine-Related Cancer 19 (3), 233-241, 2012 | 99 | 2012 |
| c-Src regulates Akt signaling in response to ghrelin via β-arrestin signaling-independent and-dependent mechanisms M Lodeiro, M Theodoropoulou, M Pardo, FF Casanueva, JP Camina PloS one 4 (3), e4686, 2009 | 95 | 2009 |
